One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Outlook Highlights The Next Major Growth Opportunities
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Growth Potential: How Will Market Size Change Through 2030?
The market size for the one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics has witnessed exponential growth in recent years. This market is expected to increase from $1.49 billion in 2025 to $1.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 20.1%. The historical expansion can be attributed to several factors including advances in molecular diagnostics, the broadening scope of crispr research, an increase in infectious disease testing, a surge in demand for rapid tests, and developments in genomics technology.
The market for the one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $3.75 billion, showing a compound annual growth rate (CAGR) of 20.4%. This foreseen development is driven by factors such as the proliferation of point-of-care molecular testing, a heightened need for swift pathogen detection, advancements in personalized diagnostics, greater clinical integration of CRISPR, and the availability of broader field-deployable testing options. Prominent trends within this period include rapid CRISPR-based diagnostic assays, point-of-care CRISPR testing kits, multiplex gene detection panels, portable molecular CRISPR platforms, and affordable nucleic acid detection kits.
Download A Free Sample Report For Comprehensive Market Insights:
One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Development Factors: Which Trends Are Supporting Demand?
The increasing occurrence of infectious diseases is anticipated to boost the expansion of the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market in the future. Infectious diseases are conditions caused by harmful microorganisms entering the body and can spread via contact, air, water, or vectors. The rise in these diseases is linked to urbanization and high population density, which promote quicker pathogen transmission. HOLMES CRISPR Diagnostics aids in detecting infectious diseases through the rapid and accurate identification of specific pathogen genetic sequences using CRISPR-Cas enzymes, enabling swift, sensitive, and point-of-care diagnoses. For example, in February 2024, data from GOV.UK, a UK-based government department, indicated that tuberculosis (TB) cases in England saw a 10.7% increase in 2023, moving from 4,380 in 2022 to 4,850. Consequently, the growing prevalence of infectious diseases is propelling the growth of the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market. The growing adoption of precision medicine is projected to drive the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market forward. Precision medicine delivers personalized healthcare by factoring in an individual’s genetic makeup, environmental influences, and lifestyle choices. This approach is gaining traction due to advancements in genomics, which enable medical professionals to pinpoint genetic variations and formulate targeted treatments, thereby enhancing patient outcomes. The HOLMES CRISPR diagnostics system supports precision medicine by quickly and precisely identifying specific genetic mutations or pathogens in a patient’s DNA or RNA, allowing for customized treatments and early interventions based on a person’s unique genetic profile. As an illustration, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, an increase from six in 2022. Additionally, the new personalized treatments approved in 2023 included seven cancer drugs and three for other illnesses and conditions. Therefore, the increasing utilization of precision medicine is fostering the growth of the hybrid oligonucleotide-linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market.
One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Segment Performance And Strategic Opportunities
The one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics market covered in this report is segmented –
1) By Product Type: Kits; Instruments; Reagents; Other Product Types
2) By Service Type: Sample Collection And Preparation Services; Assay Development And Validation Services; Data Interpretation And Reporting Services; Quality Control And Assurance Services
3) By Application: Infectious Disease Diagnosis; Oncology; Genetic Disease Screening; Other Applications
4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End-Users
Subsegments:
1) By Kits: Single Target Diagnostic Kits; Multiplex Diagnostic Kits; Point Of Care Testing Kits; Laboratory Use Diagnostic Kits; Disease Specific Diagnostic Kits
2) By Instruments: Benchtop Diagnostic Instruments; Portable Diagnostic Devices; Automated Detection Systems; Sample Preparation Instruments; Integrated Analysis Platforms
3) By Reagents: Enzyme Based Reagents; Nucleic Acid Extraction Reagents; Amplification Reaction Reagents; Detection And Reporting Reagents; Sample Stabilization Reagents
4) By Other Product Types: Consumables And Accessories; Quality Control Materials; Calibration Standards; Disposable Testing Components; Supporting Laboratory Supplies
One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Integrated DNA Technologies Inc., GenScript Biotech Corporation, OraSure Technologies Inc., Molbio Diagnostics Pvt. Ltd., New England Biolabs Inc., Horizon Discovery Group plc, Mammoth Biosciences, Synthego Corporation, Binx Health Inc., Sherlock Biosciences Inc., Caspr Biotech, Tolo Biotechnology Co. Ltd., CrisprBits Private Limited, Scope Biosciences.
Access The Complete One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Report:
One-Hour Low-Cost Multipurpose Highly Efficient System (HOLMES) Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Diagnostics Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the hybrid oligonucleotide linked modular enzyme system (HOLMES) clustered regularly interspaced short palindromic repeats (CRISPR) diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the one-hour low-cost multipurpose highly efficient system (holmes) clustered regularly interspaced short palindromic repeats (crispr) diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model